Stay updated on Pimavanserin Safety in Neurodegenerative Disease Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin Safety in Neurodegenerative Disease Clinical Trial page.

Latest updates to the Pimavanserin Safety in Neurodegenerative Disease Clinical Trial page
- CheckyesterdayChange DetectedThe study record history now includes a new revision entry labeled v3.6.5, replacing the previous v3.6.4 entry as part of an incremental update to the page's version history.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study record history now includes a new revision entry v3.6.4, while the previous revision v3.6.3 is removed from the visible history, indicating an update to the page's version tracking.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe record history now shows the latest revision as v3.6.3, replacing the previous v3.6.2. This reflects a metadata update to the study record version.SummaryDifference0.1%

- Check43 days agoChange DetectedThe revision label in the page history has been updated from v3.6.0 to v3.6.2, reflecting a UI/software update to the history view.SummaryDifference0.1%

- Check58 days agoChange DetectedThe history now records that recruitment has ended and adds a new revision label v3.6.0; it also shows the removal of the previous revision label v3.5.5.SummaryDifference0.3%

- Check65 days agoChange DetectedThe history now includes a new revision entry Revision: v3.5.5, and the previous entry Revision: v3.5.4 has been removed from the list.SummaryDifference0.1%

Stay in the know with updates to Pimavanserin Safety in Neurodegenerative Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin Safety in Neurodegenerative Disease Clinical Trial page.